Grainger (W.W.) Inc. (GWW) Pops 5.76% for February 04

Equities Staff |

One of the S&P 500’s big winners for Thursday February 04 was Grainger (W.W.) Inc. (GWW) as the company’s stock climbed 5.76% to $207.81 on volume of 1.24 million shares.

The stock opened at $201.37 and saw an intraday low of $199.35 and an intraday high of $212.65. All told, the day saw a per-share gain of $11.325. The stock’s average daily volume of 842,115 and 62.79 million shares outstanding. Grainger (W.W.) Inc. now has a 50-day SMA is $195.55 and 200-day SMA is $218.26, and it has a 52-week high of $252.87 and a 52-week low of $176.85.

W W Grainger Inc is a distributor of maintenance, repair and operating supplies and other related products and services used by businesses and institutions in the United States and Canada, with expanding operations.

Based out of Lake Forest, IL, Grainger (W.W.) Inc. has 23,600 employees and, after today’s trading, reached a market cap of $13.05 billion. The stock’s P/E Ratio is 16.3. Its P/S ratio is 1.65, P/B ratio is 5.53, and P/FCF ratio is -55.2.

For a complete fundamental analysis analysis of Grainger (W.W.) Inc., check out’s Stock Valuation Analysis report for GWW. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…